Munoz Kevin 4
4 · Silo Pharma, Inc. · Filed Jan 3, 2022
Insider Transaction Report
Form 4
Munoz Kevin
Director
Transactions
- Award
Non-Qualified Stock Option
2021-12-29+171,233→ 171,233 totalExercise: $0.15From: 2021-12-29Exp: 2026-12-29→ Common Stock (171,233 underlying)
Footnotes (2)
- [F1]Vests over the course of one year from grant with 100% vesting a year from the date of grant.
- [F2]The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan.